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Abstract
Background: Not all echo laboratories have the capability of measuring direct online 3D images, but do have the
capability of turning 3D images into 2D ones “online” for bedside measurements. Thus, we hypothesized that a simple
and rapid rotation of the sagittal view (green box, x-plane) that shows all needed left atrial appendage (LAA) number of
lobes, orifice area, maximal and minimal diameters and depth parameters on the 3D transesophageal echocardiography
(3DTEE) image and LAA measurements after turning the images into 2D (Rotational 3DTEE/“Yosefy Rotation”) is as
accurate as the direct measurement on real-time-3D image (RT3DTEE).
Methods: We prospectively studied 41 consecutive patients who underwent a routine TEE exam, using QLAB 10
Application on EPIQ7 and IE33 3D-Echo machine (BORTHEL Phillips) between 01/2013 and 12/2015. All patients
underwent 64-slice CT before pulmonary vein isolation or for workup of pulmonary embolism. LAA measurements were
compared between RT3DTEE and Rotational 3DTEE versus CT.
Results: Rotational 3DTEE measurements of LAA were not statistically different from RT3DTEE and from CT regarding:
number of lobes (1.6 ± 0.7, 1.6 ± 0.6, and 1.4 ± 0.6, respectively, p=NS for all); internal area of orifice (3.1 ± 0.6, 3.0 ± 0.7,
and 3.3 ± 1.5 cm2, respectively, p =NS for all); maximal LAA diameter (24.8 ± 4.5, 24.6 ± 5.0, and 24.9 ± 5.8 mm,
respectively, p =NS for all); minimal LAA diameter (16.4 ± 3.4, 16.7 ± 3.3, and 17.0 ± 4.4 mm, respectively, p =NS for all),
and LAA depth (20.0 ± 2.1, 19.8 ± 2.2, and 21.7 ± 6.9 mm, respectively, p =NS for all).
Conclusion: Rotational 3DTEE method for assessing LAA is a simple, rapid and feasible method that has accuracy similar
to that of RT3DTEE and CT. Thus, rotational 3DTEE (“Yosefy rotation”) may facilitate LAA closure procedure by choosing
the appropriate device size.
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Background
Ninety percent of clots in patients with non-valvular
atrial fibrillation (AF) occur in the left atrial appendage
(LAA). The shape and location of LAA allow for stasis
of blood in AF, mitral stenosis (MS), and other low
cardiac output conditions. Clots may remain hidden be-
cause of the three-dimensional (3D) complexity of the
LAA [1, 2]. Complex LAA morphology characterized by
an increased number of LAA lobes (≥3) was associated
with the presence of LAA thrombus independently of
clinical risk and blood stasis [1].
Over the last years, minimally invasive epicardial tech-
niques and catheter-based transseptal techniques have
been developed for occlusion of the LAA orifice to re-
duce stroke risk [3–5]. These devices and procedures
may provide an alternative to oral anticoagulation
(OAC) for AF patients at high risk for stroke but with
contraindications for chronic OAC [6–8].
Accurate knowledge of LAA anatomy and dimensions
has become a key guiding stage before introducing LAA
closure devices [7, 9, 10]. LAA assessment should be done
prior to procedure [7, 11–13]. Currently, 2D transesopha-
geal echocardiography (2DTEE) at a cut plane angulation
of 135° is the recommended method to size maximal LAA
orifice diameter before introducing a percutaneous LAA
closure device [9, 10, 14, 15]. However, 2DTEE does not ad-
equately allow complete spatial visualization of the LAA
[11–13, 16]. Thus, three-dimensional imaging modalities
[11–13] such as cardiac magnetic resonance imaging
(MRI), computed tomography (CT), and Real-Time-3-Di-
mensional Transesophageal Echocardiography (RT3DTEE)
may be more accurate [15, 17–19].
Recent trials show better performance of RT3DTEE
for the assessment of LAA anatomy compared with
2DTEE regarding LAA orifice area, LAA ejection frac-
tion calculation, and LAA volume [15, 20–22]. Our
group showed that bedside direct online RT3DTEE mea-
surements of LAA maximal orifice diameter are more
accurate than 2DTEE measurements and are as accurate
as CT as gold standard [16]. Thus, direct RT3DTEE
measurements may facilitate LAA closure procedure by
choosing the appropriate device size. However, not all
echo laboratories have the capability of using this
method that directly measures the 3D images
(RT3DTEE) but yet have the capability to online turn
3D images into 2D ones for bedside measurements.
We analyzed LAA measurements using a simpler and
faster 3D method: after conversion of the 3D image into
three 2D planes (X,Y,Z), the operator uses a 360° rota-
tion of the sagittal plane (green box, x-plane), that en-
ables him to rapidly choose the image which shows all
the LAA parameters needed for the introduction of the
invasive procedure in one single “stop shop” image
(Rotational 3DTEE/“Yosefy Rotation”). Our aim was to
validate the accuracy of Rotational 3DTEE versus the former
direct online RT3DTEE method for LAA assessment.
Methods
Study population
A total of 41 consecutive patients who underwent a rou-
tine indicated 3DTEE and 64-slice CT, either before pul-
monary vein isolation (PVI) ablation (n = 34) for precise
definition of LA and pulmonary veins anatomy, or for
workup of pulmonary embolism (PE) (n = 7) (Table 1).
In this group of patients, 64-slice CT was used as refer-
ence technique to test the accuracy of 3DTEE-derived
measurements of LAA parameters. We compared Rota-
tional 3DTEE LAA measurements versus RT3DTEE.
Echocardiography
Forty-one consecutive patients (out of 43 patients) who
underwent the routine echocardiography exam using
EPIQ7 and iE33 echo machine (Philips Medical Systems,
Andover, MA) between January 2013 and December 2015
and had a good echogenic window, were included in the
study. All images were digitally stored for offline analysis
(QLAB 10.0 cardiac 3DQ, Philips Medical Systems).
Table 1 Baseline demographics and echocardiographic
characteristics of the study population
Study population (n = 41)
Age (years) 62.9 ± 12.7
Male 21 (51 %)
BSA (m2) 1.9 ± 0.2
Height (meters) 1.7 ± 0.1
Weight (kg) 84.1 ± 15.9
Indication of CT Before PVI – 34
PE workup – 7
Echocardiographic measurements (RT3DTEE)
LVEF (est. %) 59.9 ± 6.9
LPW-D (mm) 10.1 ± 0.2
IVS-D (mm) 10.8 ± 2.4
LVESD (mm) 31.3 ± 3.7
LVEDD (mm) 48.8 ± 4.5
Pulmonary pressure (mmHg) 33.0 ± 14.0
RA area (cm2) 17.6 ± 4.5
LA area (cm2) 22.7 ± 5.3
LA diameter (ap) (mm) 39.8 ± 6.8
Ascending aorta diameter (mm) 32.4 ± 3.4
Aortic root diameter (mm) 30.4 ± 3.2
BSA body surface area, CT computed tomography, est estimated, IVS-D
inter-ventricular septum diameter, LPW-D left posterior ventricular wall
diameter, LVEDD left ventricular end diastolic diameter, LVEF left ventricular ejection
fraction, LVESD left ventricular end systolic diameter, PE pulmonary embolism, PVI
pulmonary vein isolation, RT3DTEE real-time 3-dimensional transesophageal
echocardiography
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Internal area of LAA orifice, LAA depth, maximal
LAA diameter, minimal LAA diameter, and number of
LAA lobes were compared between Rotational 3DTEE
and RT3DTEE and to the CT as the gold standard
method. All echocardiographic data have been reviewed
by a single operator (CY) who was blinded to CT results
done by a single operator (YA).
Transesophageal echocardiography
Transesophageal echocardiography (TEE) was performed
using a commercially available fully sampled matrix-array




RT3DTEE imaging was performed acquiring the usual pyr-
amidal data set large enough to include the entire LAA.
The zoom mode was used to improve visualization of LAA.
The internal area of the LAA orifice, as well as the
minimal and maximal diameters of the LAA orifice
(Dmax and Dmin, respectively), were measured directly
from the original 3D views, along a plane connecting the
origin of the left Circumflex artery to the roof of the
LAA, below the ligament of Marshall, as previously
shown by our group [16]. These measurements were
assessed online using the EPIQ 7 echo machine (Philips
Medical Systems, Andover, MA), since they could not be
measured off-line on QLAB 10.0 software. The LAA
depth (i.e., the longest distance from LAA orifice at the
Circumflex artery level to the tip of the LAA) was mea-
sured off-line from the long-axes views, using dedicated
software (QLAB 10.0). On these datasets we tried to
measure LAA 3D volume using the same tracking
method that we used for LA volume measurement, as
previously described [23].
Rotational 3DTEE
Our 3D protocol for LAA dimensions measurements
was as follows: Data acquisition included all the LAA in
3D zoom mode. We chose the 3DQ (and not 3DQadv)
application and found the ECG guided end systole (i.e.,
end of T-wave) for the maximal LAA dimensions. We
magnified multiplanar reconstruction (MPR) 2D images,
then adjusted and cropped the lines to the optimal align-
ment. After optimizing the blue line to the circumflex
artery level and decreasing the gain in the volume mode,
we took the sagittal plane (green box, x-plane) and
screened a 360° rotation. This 360° rotation (“Yosefy
rotation”), is simpler and faster 3D method: it uses a ro-
tation of the sagittal plane (in the green box, x-plane)
that enables the operator to rapidly choose the image
which gives him all the LAA parameters needed to
introduce the invasive procedure in one single “stop
shop” image (including: number of lobes - during the ro-
tation; orifice area; maximal and minimal diameters - in
the axial blue box; and depth - in the green box). In con-
trast to the usual time consuming MPR methods, in
which each of the above parameters is taken at different
angles (0°, 45°, 90°, 135°) and frames, using our rotation,
we could easily find the “stop shop” image point where
all the above LAA parameters are measured (Fig. 1).
All 3D measurements of LAA were performed at ven-
tricular end-systole. All the patients included in our
study were in sinus rhythm during the echocardio-
graphic studies. Nevertheless, in patients who are in
Fig. 1 Three dimensional transesophageal echocardiography (3DTEE) measurements of left atrial appendage (LAA) using 360°, Rotational 3DTEE
method (see text and panel a); and measurement of maximal (Dmax) and minimal (Dmin) diameters at the level of the circumflex (Cx) artery
(panel b Video clip is attached)
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atrial fibrillation at the time of transesophageal echocar-
diography (TEE), we usually average measurements from
≥3 cardiac cycles.
Sixty-four-slice computed tomography
All forty-one patients underwent clinically indicated 64-
slice CT (Philips Brilliance CT 64 Power-Philips Medical
Systems, Eindhoven, The Netherlands) within one week
of transthoracic and transesophageal echocardiography.
All patients were in sinus rhythm during the CT scan. A
retrospective ECG-gating protocol was used. Scanning
parameters were the following: detector collimation of
0.625 mm, total z-axis coverage of 40 mm per rotation,
gantry rotation speed of 0.35 s, tube voltage of 120 kV,
pitch of 0.16 to 0.24, and ECG modulated tube current
ranging from 400 to 800 mA. The bolus tracking
technique was used to trigger the acquisition, with a
four-cavity view as the region of interest. A total of 70–
100 mL of iodinated, nonionic contrast agent (Iomeron
350, Bracco Imaging S.p.A.) was injected continuously
into the antecubital vein (100–120 mL at 5.0 mL/s).
Scanning was initiated during a single breath hold for an
acquisition time of 5 to 7 s. All images were recon-
structed with an effective slice thickness of 0.625 mm.
ECG-gating protocol reconstruction of the image data
was performed starting from early systole (10 % of R-R
interval) and ending at end-diastole (90 % of R-R inter-
val) using 10 % steps. Reconstructed image data were
transferred to a remote workstation (IntelliSpace Portal,
Philips) for post-processing. For the purpose of the
current study, image data sets reconstructed at end-
systole (40 % of R-R interval) were used for analysis.
Using MPR, measurements of the area of the LAA ori-
fice were performed from the short-axis view as well as
the maximum (Dmax) and minimum (Dmin) diameters
(Fig. 2), and the maximum depth of LAA was measured
as the longest distance from LAA orifice to the tip of
LAA. All the patients included in our study were in
sinus rhythm during the imaging studies. Nevertheless,
in patients who are in atrial fibrillation at the time of CT
scanning, we usually average measurements from ≥3
cardiac cycles.
Statistical analysis
Continuous variables are presented as percentages and
means ± standard deviation. Categorical data are pre-
sented as absolute numbers and percentages. Continu-
ous variables were compared using independent Student
t-test; categorical variables were compared using chi-
square test or Fisher’s exact test. A 2-sided p-value < .05
was considered to indicate statistical significance for all
tests. Analyses were carried out using SPSS version 21.0
statistical package (SPSS IBM. Inc.).
The intra-observer reproducibility of Rotational
3DTEE method for the measurement of all LAA param-
eters was demonstrated by performing the measure-
ments of Rotational 3DTEE and CT in 10 randomized
patients from our study by the same operator (CY for
the TEE and YA for the CT), to assure they were not
significantly different by paired t test. The measurements
of LAA orifice area, maximal and minimal diameters
and depth were calculated to obtain their SD and test
the mean value versus 0.
Inter-observer variability was assessed between two
observers in 10 patients selected randomly from our
study patients. The measurements using Rotational
3DTEE and CT methods were obtained independently
by two expert operators for each modality (CY and
Doodit Mimon for the TEE and YA and Victor Lapis for
the CT) blinded to the results of each other. Inter-
observer variability was defined as the SD of the differ-




Baseline characteristics of the study population (n = 41)
are shown in Table 1. All patients had full readable
Fig. 2 CT images of LAA orifice maximal diameter and area at the
level of circumflex (Cx) artery (arrow). (Dmax = largest diameter,
Dmin =minimal diameter)
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Rotational 3DTEE and RT3DTEE images. Thus, there was
100 % feasibility of LAA assessment.
Comparison between Rotational 3DTEE and RT3DTEE
Rotational 3DTEE measurements of LAA were not statis-
tically different from RT3DTEE regarding: number of
lobes (1.6 ± 0.7 and 1.6 ± 0.6, respectively, p =NS); area of
orifice (3.1 ± 0.6 and 3.0 ± 0.7 cm2, respectively, p =NS);
maximal LAA diameter (24.8 ± 4.5, 24.6 ± 5.0 mm, re-
spectively, p =NS) (Fig. 3); minimal LAA diameter (16.4 ±
3.4, 16.7 ± 3.3 mm, respectively, p =NS) (Fig. 4); and LAA
depth (20.0 ± 2.1 and 19.8 ± 2.2 mm, respectively, p =NS)
(Fig. 5).
As in our previous study [16], LAA volume could not
be measured directly using RT3DTEE due to inability of
the technology to track the lobe borders.
Comparison between Rotational 3DTEE and CT
Rotational 3DTEE measurements were not different from
CT measurements regarding: number of LAA lobes (1.6 ±
0.7 and 1.4 ± 0.6, respectively, p =NS); area of orifice (3.1 ±
0.6 and 3.3 ± 1.5 cm2, respectively, p =NS); maximal LAA
diameter (24.8 ± 4.5, 24.9 ± 5.8 mm, respectively, p =NS)
(Fig. 3); minimal LAA diameter (16.4 ± 3.4, 17.0 ± 4.4 mm,
respectively, p =NS) (Fig. 4); and LAA depth (20.0 ± 2.1
and 21.7 ± 6.9 mm, respectively, p =NS) (Fig. 5).
The Bland-Altman analysis shows good correlation
and low variability between LAA orifice area, maximal
and minimal diameters and depth measured by Rota-
tional 3DTEE and by CT scanning (Fig. 6a-d).
Inter-observer variability of LAA orifice area, maximal
and minimal diameters and depth measured by Rota-
tional 3DTEE and by CT scan methods was calculated
and compared between the two observers. The variabil-
ity of the mean values was 3.9, 4.1, 2.9 and 3.1 %, re-
spectively, for the Rotational 3DTEE, and 3.2, 3.6, 2.7
and 3.8 %, respectively, for the CT. The observers con-
cordance was with good agreement (r = 0.97, 0.95, 0.95
and 0.97, respectively) between the two methods.
Intra-observer variability of calculated LAA orifice
area, maximal and minimal diameters and depth mea-
surements for the Rotational 3DTEE were 3.9, 2.8, 4.3
and 3.5 %, respectively, and for the CT scan method: 3.7,
2.3, 3.9 and 2.7 %, respectively, indicating a reasonable
range of variability for this technique. The same obser-
ver concordance of different measurements was with
good agreement (r = 0.95, 0.94, 0.95 and 0.97, respect-
ively) for the Rotational 3DTEE and r = 0.95, 0.94, 0.99,
0.95, respectively, for the CT scan method.
Discussion
Precise knowledge of LAA anatomy and dimensions has
become a key guiding stage before implanting LAA clos-
ure devices [7, 9–13, 24]. Bedside RT3DTEE measure-
ments of LAA maximal orifice diameter were shown to
be more accurate than 2DTEE and are as accurate as
CT as the gold standard [16]. However, not all echo la-
boratories have the capability of measuring direct online
3D images, but do have the capability of turning 3D im-
ages into 2D ones “online” for bedside measurements.
In this study we introduced a simpler and faster 3D
method: it uses a rotation of the sagittal plane (green
box, x-plane), that enables the operator to rapidly
choose the image which gives him all the LAA parame-
ters needed for the invasive procedure in one single
“stop shop” image. This includes number of lobes, orifice
Fig. 3 Histogram comparing LAA maximal diameter using different imaging methods (n = 41). Comparison between computed tomography (CT)
(24.9 ± 5.8 mm), direct Real-Time 3-Dimensional Transesophageal Echocardiography (3D) (24.6 ± 5.0 mm), and Rotational 3DTEE (3D Rotate) (24.8
± 4.5 mm), (p = NS for all)
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area, maximal and minimal diameters and LAA depth.
In contrast to the usual time consuming MPR methods,
in which each of the above parameters are taken in dif-
ferent angles (0°, 45°, 90°, 135°) and frames, using our ro-
tation, we could easily find the “stop shop” image point
where all LAA parameters are measured (Fig. 1).
Thus, rotational 3DTEE (Yosefy rotation) may facili-
tate percutaneous LAA closure procedure for stroke
prophylaxis in patients with non-valvular AF by choos-
ing the appropriate LAA closure-device size. As it is
simple and fast it can be repeated as many times needed
before and during the procedure to ensure device size
and proper implantation and LAA closure. Its accuracy
is emphasized by the Bland-Altman analysis that shows
good correlation and low variability between LAA orifice
area, maximal and minimal diameters and depth mea-
sured by Rotational 3DTEE (3D Rotate) and by CT scan-
ning (Fig. 6a-d). Also, the calculated differences between
LAA orifice area, maximal and minimal diameters and
depth were concordant (r = around 0.95), indicating a
reasonable range of variability for this technique.
Recent evolving data show better performance of
RT3DTEE for the assessment of LAA anatomy com-
pared with 2DTEE [13, 15, 16, 20–22]. Nucifora et al.
[20] have published a study showing that RT3DTEE is
more accurate than 2DTEE for assessment of LAA
Fig. 4 Histogram comparing LAA minimal diameter using different imaging methods (n = 41). Comparison between computed tomography (CT)
(17.0 ± 4.4 mm), direct Real-Time 3-Dimensional Transesophageal Echocardiography (3D) (16.7 ± 3.3 mm), and Rotational 3DTEE (3D Rotate)
(16.4 ± 3.4 mm), (p = NS for all)
Fig. 5 Histogram comparing LAA depth using different imaging methods (n= 41). Comparison between computed tomography (CT) (21.7 ± 6.9 mm),
direct Real-Time 3-Dimensional Transesophageal Echocardiography (3D) (19.8 ± 2.2 mm), and Rotational 3DTEE (3D Rotate) (20.0 ± 2.1 mm), (p=NS for all)
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orifice area: 137 patients (99 of them had AF) underwent
2DTEE and RT3DTEE, with CT used as a reference in 46
of them. RT3DTEE showed higher correlation with CT for
the assessment of LAA orifice area, compared with
2DTEE. Our group showed in a previous study [16] that
although no difference was found between LAA depth
measurements using RT3DTEE and 2DTEE, compared to
measurements with the direct RT3DTEE method, in
23.3 % of patients the commonly “recommended” 135°
2DTEE was not the cut plane angulation with maximal
orifice diameter, thus underestimating this diameter and
potentially complicating proper implantation of the de-
vice. In contrast, bedside RT3DTEE LAA measurements
were not statistically different from those with CT.
Our method to size the LAA is different from the
three methods that are already being used. The three
methods include: the standard 2D methods using four
angles (0°, 45°, 90°, 135°) [7], the 3D multiplane recon-
struction (MPR) method using the three orthogonal
planes from the three original pyramid 3D volume data-
set [20], and the 3D TEE with on-image caliper meas-
urement, as described in our previous work [16]. The
main difference in our current technique is that we do
not use different MPR orthogonal planes to find each of
the LAA parameters, but we use a “stop shop” image
point where all LAA parameters are measured. Thus,
this technique enhances the time and simplifies LAA
measurements, as shown in the attached video clip and
in Fig. 1.
Thus, RT3DTEE is slowly evolving as a first-line method
for sizing LAA due to its accuracy and its real-time and
inherent bedside capabilities [16, 25, 26]. Compared to CT
and MRI, it is faster, cheaper, and more comfortable to ac-
cess; and as opposed to CT it is not associated with radi-
ation exposure and contrast administration, while
providing high quality images [27]. It may lower the cost
of LAA closure procedure by also avoiding the need to ex-
change unsuitable devices and may reduce the risk of
complications by lowering the number of failed attempts
due to inappropriate device size [28, 29]. These advantages
are in addition to its excellent capabilities in ruling out LA
thrombus prior to the procedure [30].
The closure device is available in various sizes to ac-
commodate individual variations on LAA anatomy.
Proper positioning and sizing are essential for safety and
efficacy (ref ). Undersizing of the device has the potential
risk of device migration or embolization and may favor
peri-device leakage. Oversizing of the device should also
be avoided because this may cause cardiac perforation,
pericardial effusion, and cardiac tamponade.
Important aspects for LAA occlusion include the cor-
rect sizing of the landing zone diameters for the selected
device and the measurement of the depth and orientation
of the main anchoring lobe and the number and origin of
additional lobes. Because of the substantial variations in
LAA anatomy that impact device selection and efficacy,
an accurate assessment of anatomic LAA characteristics is
crucial before an LAA closure procedure [24].
Fig. 6 Bland-Altman analysis of differences between left atrial appendage (LAA) orifice area (a), depth (b), maximal (c), and minimal (d), diameters
by CT scanning Vs. Rotational 3DTEE
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The choice of an appropriate occlusion device depends
on accurate measurements of the landing zone diame-
ters. To achieve a secure and stable device position, the
size of the occlusion device is usually selected to be a
few millimeters larger in diameter than the measure-
ments of the landing zone. The maximum length of the
anchoring lobe has to be measured in addition (in the
expected axis of the device) to ensure that this lobe has
enough space to accommodate the selected device. Dif-
ferent device types require different measurements be-
cause the different occluder systems vary slightly. The
angle between the ostium, the neck, and the main an-
choring lobe should be evaluated because it can influ-
ence the choice of the puncture site and/or the curve of
the delivery sheath. The number and origin of additional
LAA lobes also needs to be assessed. Some LAA morph-
ologies are more challenging for device closure than
others; thus, LAA anatomy should be defined before any
planned closure-device procedure [24].
Previous works [1, 20] used MPR for measurements on
the 3D images and only as a second stage analysis do they
measure LAA size by using the cut planes of each lobule
at the X,Y,Z axes. Our group described a new method that
measures LAA size directly on the 3D image [16]. The ad-
vantages of this method are its efficiency and speed. The
measurements are given immediately, bedside, without
the need for further analysis of the image.
Many echo laboratories have the capability of turning
3D images into 2D ones “online” for bedside measure-
ments but some of them do not have the capability of
measuring direct online 3D images (i.e., RT3DTEE) as
we have shown before [16]. Thus, we tried to use a sim-
pler, practical method for measuring LAA size that com-
bines the accuracy and real time capabilities of 3D echo
on one hand, and the simplicity and bedside availability
of 2D echo on the other hand.
We showed that a fast and simple rotation of the intro-
ducer that demonstrates maximal diameter of LAA orifice
on the 3D image (Yosefy rotation) and LAA measure-
ments after turning the images into 2D (Rotational
3DTEE) has a similar accuracy to that of the former direct
measurement on 3D image (RT3DTEE) and to CT. Our
3D protocol for LAA dimensions measurements was de-
scribed in detail. We showed that rotational 3DTEE mea-
surements of LAA were not statistically different from
RT3DTEE and from CT regarding number of lobes, in-
ternal area of LAA orifice, maximal LAA diameter, and
LAA depth. We believe that either RT3DTEE or Rota-
tional 3DTEE should replace CT scan before and during
implantation of percutaneous LAA occlusion devices.
Limitations
Whenever there is a need for volume measurement by
3D echocardiography, MPR can be applied (by using cut
planes of each lobule at the X,Y,Z axes, calculating the
volume and adding to the volume of the other lobes).
However, this method is not practical, is slow and ineffi-
cient, and thus was not used in our 3DTEE studies.
Conclusions
Rotational 3DTEE method is a fast, simple and feasible
method that has similar accuracy as RT3DTEE and CT
in assessing LAA anatomy. Thus, bedside rotational
3DTEE may facilitate LAA closure procedure by choos-
ing the appropriate device size.
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